Abstract: ［Abstract］〓Objective〖HTSS〗〓To investigate the clinical efficacy of plasma electroresection and laser vaporization in the treatment of benign prostatic hyperplasia and their influence on international prostate symptom score(IPSS),quality of life(QOL),maximum urine flow rate(Qmax) and postvoid residual volume(PVR).
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓A total of 78 patients with benign prostatic hyperplasia who underwent surgical resection were analyzed retrospectively. Among them, 43 patients treated with transurethral plasmakinetic bipolar resection were labeled as electroresection group and 35 patients treated with 1 470 nm semiconductor laser vaporization were labeled as laser groups. The clinical efficacy, intraoperative hemoglobin(HB) falling value, blood sodium falling value, bladder irrigation time, operation time, indwelling catheter time and hospitalization time of the two groups were compared.IPSS, QOL, Qmax and PVR before and after treatment and complications such as intraoperative and postoperative bleeding, secondary bleedingand transurethral resection syndrome were compared.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓There was no statistically significant difference in clinical efficacy and total effective rate between two groups(P＞005). The HB falling value and blood sodium falling value in laser group were significantly lower than those in electroresection group, bladder irrigation time, indwelling catheter time and hospitalization time were significantly shorter than those in electroresection group, and the operation time was significantly longer than that in electroresection group(P＜005). Before treatment, there was no significant difference in IPSS, QOL, Qmax and PVR between two groups(P＞005). After treatment, IPSS, QOL, PVR in the two groups were significantly lower than that before treatment. Qmax was significantly higher than that before treatment, and the difference was statistically significant(P＜005). However, there was no significant difference in IPSS, QOL, Qmax and PVR between two groups(P＞005). There was no significant difference in the incidence of adverse reactions between two groups(P＞005).
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓Both 1 470 nm semiconductor laser vaporization treatment and transurethral plasmakinetic bipolar resection treatment have significant clinical effects in the treatment of benign prostatic hyperplasia, they can effectively improve the patient′s IPSS, QOL, Qmax and PVR, transurethral plasmakinetic bipolar resection treatment is with shorter operation time, 1 470 nm semiconductor laser vaporization treatment is with less bleeding.

Key words: prostatic hyperplasia, transurethral resection of prostate, lasers, semiconductor